Rallybio Corporation
RLYB
$0.298
-$0.0029-0.96%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 3.68% | 29.38% | 14.68% | 5.99% | -10.17% |
| Total Depreciation and Amortization | -6.25% | -5.88% | -2.86% | -2.78% | -2.70% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -10.59% | 16.97% | -11.10% | -10.82% | -2.87% |
| Change in Net Operating Assets | 79.14% | -216.75% | 191.48% | -78.48% | 949.37% |
| Cash from Operations | 27.19% | -30.02% | 32.60% | -32.74% | 29.30% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -107.08% | 755.35% | -74.71% | -39.34% | 451.17% |
| Cash from Investing | -107.08% | 755.35% | -74.71% | -39.30% | 450.78% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -100.00% | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 100.00% | 95.72% | -- | -- | -- |
| Cash from Financing | 263.64% | -100.21% | -- | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -232.00% | 428.86% | 49.35% | -197.32% | 139.82% |